Trial Profile
Platelet Function in Diabetic Patients With and Without Renal Impairment, and the Effects of Lipid Lowering Treatment.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Apr 2022
Price :
$35
*
At a glance
- Drugs Ezetimibe (Primary) ; Simvastatin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Acronyms PLAUDIT
- 25 Feb 2011 Actual end date (Jun 2010) added as reported by ClinicalTrials.gov.
- 25 Feb 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 30 Dec 2009 New trial record